Krasimira K.
- Country
- Bulgaria
- Department
- Second Children Clinic
Research Overview
- A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab with Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) with Moderately to Severely Active Crohn's Disease
- A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib with Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitis and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy
- A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age with Functional Constipation (FC).
Data & Insights
Has run more than one trial at 16 of 57 partner sites.
Specializations
Pediatric Gastroenterology
The investigator specializes in treating inflammatory bowel diseases in pediatric populations, with particular focus on Crohn's disease and ulcerative colitis.
- Moderate to severe IBD management
- Novel therapeutic approaches
- Treatment-resistant cases
Their research encompasses innovative therapeutic solutions for children who have not responded adequately to conventional treatments.
Functional Gastrointestinal Disorders
The investigator focuses on treating functional constipation in young children, particularly those between 6 months and 5 years of age.
- Early childhood constipation
- Long-term therapeutic outcomes
- Age-specific treatment approaches
Their work addresses the specific challenges of managing functional gastrointestinal disorders in very young patients.
Pediatric Clinical Pharmacology
The investigator studies pharmacokinetics and therapeutic responses in pediatric populations, with emphasis on gastrointestinal conditions.
- Age-appropriate dosing strategies
- Safety monitoring in children
- Treatment efficacy assessment
Their research examines the safety and effectiveness of various therapeutic agents across different pediatric age groups.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.